Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.62 CAD | -2.41% | -7.43% | -51.64% |
Sales 2024 * | - | Sales 2025 * | 1.04M 763K | Capitalization | 25.46M 18.64M |
---|---|---|---|---|---|
Net income 2024 * | -74M -54.18M | Net income 2025 * | -54M -39.54M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 24.4 x |
P/E ratio 2024 * |
-0.23
x | P/E ratio 2025 * |
-0.33
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.29% |
Latest transcript on Aptose Biosciences Inc.
1 day | -2.41% | ||
1 week | -7.43% | ||
Current month | -27.68% | ||
1 month | -20.98% | ||
3 months | -36.47% | ||
6 months | -53.58% | ||
Current year | -51.64% |
Managers | Title | Age | Since |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 13-10-27 |
C. Payne
DFI | Director of Finance/CFO | 61 | 22-06-26 |
Chief Tech/Sci/R&D Officer | - | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 07-09-18 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 22-09-12 |
Mark Vincent
BRD | Director/Board Member | 71 | 07-09-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.62 | -2.41% | 13,330 |
24-04-24 | 1.66 | +0.61% | 10,087 |
24-04-23 | 1.65 | -2.94% | 8,444 |
24-04-22 | 1.7 | +0.59% | 601 |
24-04-19 | 1.69 | -3.43% | 20,800 |
Delayed Quote Toronto S.E., April 25, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.64% | 19.01M | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- APS Stock